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Biomaterials as Tendon and Ligament
Substitutes: Current Developments
Mariana L. Santos, Márcia T. Rodrigues, Rui M.A. Domingues,
Rui Luís Reis and Manuela E. Gomes
Abstract Tendon and ligament have specialized dynamic microenvironment charac-
terized by a complex hierarchical extracellular matrix essential for tissue functionality,
and responsible to be an instructive niche for resident cells. Among musculoskeletal
diseases, tendon/ligament injuries often result in pain, substantial tissue morbidity, and
disability, affecting athletes, active working people and elder population. This repre-
sents not only a major healthcare problem but it implies considerable social and eco-
nomic hurdles. Current treatments are based on the replacement and/or augmentation of
the damaged tissue with severe associated limitations. Thus, it is evident the clinical
challenge and emergent need to recreate native tissue features and regenerate damaged
tissues. In this context, the design and development of anisotropic bioengineered
systems with potential to recapitulate the hierarchical architecture and organization of
tendons and ligaments from nano to macro scale will be discussed in this chapter.
Special attention will be given to the state-of-the-art fabrication techniques, namely
spinning and electrochemical alignment techniques to address the demanding
requirements for tendon substitutes, particularly concerning the importance of biome-
chanical and structural cues of these tissues. Moreover, the poor innate regeneration
ability related to the low cellularity and vascularization of tendons and ligaments also
anticipates the importance of cell based strategies, particularly on the stem cells role for
the success of tissue engineered therapies. In summary, this chapter provides a general
overview on tendon and ligaments physiology and current conventional treatments for
injuries caused by trauma and/or disease. Moreover, this chapter presents tissue engi-
neering approaches as an alternative to overcome the limitations of current therapies,
focusing on the discussion about scaffolds design for tissue substitutes to meet the
regenerative medicine challenges towards the functional restoration of damaged or
degenerated tendon and ligament tissues.
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17.1 Tendon/Ligament Physiology and Properties
Ligaments and tendons are connective tissues formed by dense bands of collage-
nous ﬁbers. The well-ordered arrangement of these ﬁbers within the tissue confers
highly anisotropic mechanical properties and parallel ﬁber arrangements from the
nano to the microscale. Tendons connect muscle to bone, allowing movement by
transmitting forces generated by the muscle to the bone, while ligaments connect
bone to bone stabilizing movement when forces are applied. Therefore these tissues
of the human body play important roles in musculoskeletal biomechanics, espe-
cially at the joint level [1–3].
Tendons and ligaments vary in size, shape, orientation and anatomical location,
although, in general, they are characterized by the presence of an abundant extra-
cellular (ECM) with a few cells, the tenocytes, dispersed in rows in between the
collagen ﬁbers. The major compound of tendon ECM is type I collagen repre-
senting 60–85 % of the tendon dry weight. Type I collagen confers stiffness and
strength to the tissue but other types of collagen exist in minor amounts, namely
type III, V, X, XI, XII and XIV collagens. Type V collagen has been associated to
type I collagen in the regulation of the collagen ﬁbril diameter while type III
collagen is functionalized in tendon repair. Type XII collagen is present in the
surface of ﬁbrils and bonds the ﬁbrils with other matrix components such as decorin
and ﬁbromodulin [4, 5]. Due to the similarities between tendon and ligament
composition as well as the complementary functions they perform in joint move-
ment, biomechanics and stability, they are often described as the same type of tissue
in tissue engineering strategies.
Tendon architecture presents a unique hierarchical organization where collagen
molecules assemble and form subunits of increasing diameter and complexity
(Fig. 17.1). The highly aligned collagen ﬁbers arranged in a longitudinal way and
parallel to the mechanical axis confer high tensile strength to the structure of these
tissues.
The mechanical role of tendons and ligaments is based on their visco-elasticity
properties allowing these structures to regain the original shape after deformation,
when the deformation load resultant from the application of an external force is
removed. This phenomenon occurs because of the high degree of resilience of these
tissues, characterized by the capacity to absorb and store energy within the elastic
range (understretch) and release that energy (when load is removed) so the tissue
matrix recoils back and restores its original shape. These tissues are also temper-
ature sensitive, which affects the rate of creep (slow elongation). For an effective
elongation, tendons and ligaments should be heated and subjected to a signiﬁcant
load over a long time period to produce creep. If the load is sudden or excessive, the
elastic limits of tendon and ligament may be exceeded and the tissue enters the
plastic domain (Fig. 17.2). In this domain, the original shape cannot be restored and
the tissue is permanently deformed. If loading forces continue over the plastic
domain, the tissue reaches the failure point, which results in ﬁber rupture
(Fig. 17.2) [1–3].
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Fig. 17.1 Schematic representation of tendon/ligament architecture hierarchically organized into
structural units. The tendon unit is composed of multiple fascicles of collagen ﬁbers that result
from the assembly of collagen ﬁbers. These ﬁbers are formed by ﬁbrils that are formed by the
aggregation of collagen molecules. This well-organized hierarchical structure from the nano to the
microscale confers the anisotropic nature of tendons and ligaments and is responsible for the
biomechanical properties of these tissues. Adapted from Ref. [6]. Copyright 2015, with permission
of Springer
Fig. 17.2 Tendon stress-strain curve. The mechanism of tendon deformation expresses a
nonlinear behavior consisting of a toe, linear, and yield regions in a stress-strain curve. Tissue
ﬁbers present a linear region until approximately 4 % strain. After that value ﬁbers have
microscopic failures and rupture by 10 % strain, showing macroscopic failure. Reprinted from Ref.
[7]. Copyright 2006, with permission from Elsevier
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Furthermore, the strength response of tendons and ligaments under loading is
determined by two main factors: size and shape of the tissue and speed of loading.
The higher the number of oriented ﬁbers in the direction of the loading the stronger
with be the tissue, especially if they are wider and thicker [2]. The biomechanical
properties of tendons and ligaments within the same joint vary signiﬁcantly
accordingly to their speciﬁc function. Knee joint is stabilized by four main liga-
ments: anterior cruciate ligament (ACL) which restrains anterior translation of the
tibia relative to the femur, posterior cruciate ligament (PSCL) restraining posterior
tibial displacement, medial collateral ligament (MCL) which restrains valgus
angulation and lateral collateral ligament (LCL) with the function of restraining
varus angulation. ACL presents the highest value of elastic modulus, ultimate
tensile strength and ultimate strain (Table 17.1) among the described tissues evi-
dencing more resistance to deformity when forces are applied to [8, 9].
17.2 Tendon and Ligament Response to Injury
and Regeneration
Tendon and ligament injuries and associated diseases are a common problem and a
leading cause of joint disability affecting athletes, active working people and the
elder population worldwide. This problematic influences the quality of life of the
affected population, once locomotion and local structure integrity are severely
compromised.
Tendon and ligament lesions can occur through acute or chronic changes or a
combination of both. Intrinsic factors as genetics, age, nutrition or misalignments
are more often associated to chronic injuries while extrinsic factors namely phar-
macological drug treatment or excessive or absence of mechanical loading have
been related to acute injuries. Acute injuries are more frequently related to sports
injuries, being the ACL the most affected to rupture in the knee joint [9, 11].
Table 17.1 Mechanical properties of tendon and ligaments of the knee
Tissue Elastic modulus
(MPa)
Ultimate tensile strength
(MPa)
Ultimate strain
(%)
References
MCL 332.3 ± 58.3 38.6 ± 4.8 17 ± 2 [8, 9]
ACL 65–447 13–46 15–44 [8, 9]
PSCL 150–447 30–36 11–19 [8, 9]
LCL 345 ± 22.4 36.4 ± 2.5 16 ± 0.8 [10]
ACL anterior cruciate ligament, MCL medial collateral ligament, PSCL posterior cruciate ligament,
LCL lateral collateral ligament
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Repetitive trauma, traumatic or chemically induced injury and disuse have been
described as major causes for pathogenic conditions. The healing or fail to heal
capacity of tendon and ligament has a dependent correlation with intrinsic and
extrinsic factors. A failed mechanism will induce molecular and histological
changes affecting cellularity, tissue extracellular matrix and vascularity resulting in
mechanical weakness, pain and eventual tear or complete rupture [12].
Tissue injury, characterized by three main stages (inflammation, necrosis and
pain), can progress toward repair or regeneration. In tissue repair scar tissue will be
formed with inflammatory cell inﬁltration, ﬁbroplasia, disorderly collagen dispo-
sition and consequently, impaired mechanical properties. On the other hand, if
regeneration occurs the tissue to heal will present few inflammatory cells, absence
of ﬁbroplasia, orderly collagen deposition and consequently, restoration of
mechanical properties and absence of ﬁbrotic tissue. Therefore regeneration is the
desired evolution of injury for a complete regain of tissue functionality.
17.3 Current Conventional Treatments
Current available management of tendon and ligament injuries rely on conservative
treatments and or surgically interventions (Table 17.2), which depend on the
physio-anatomy of tissue, symptoms and clinical ﬁndings on the type and severity
of the damage. Despite treatments, the mid to long term outcomes are not com-
pletely successful and tendon and ligament injuries will likely progress to nearby
tissues and ultimately evolve into mild to severe forms of osteoarthritis (OA).
Because of the limitations and frequent failure of nonsurgical approaches, sur-
gery remains the treatment of choice, especially for athletes suffering from ligament
injuries, who want to remain competitively active.
Despite clinical advances and knowledge on surgical management, the
replacement of damaged tissue with tissue grafting is still a gold standard despite
the morbidity and functional disability of donor tissue that may have severe con-
sequences in the long term that include pain, instability, loss of mechanical com-
petence and degeneration of both tissue and joint.
The most commonly used grafts in anterior cruciate ligament
(ACL) reconstruction are the hamstring tendon and patellar tendon. Hamstring and
bone-patellar tendon-bone autografts are described to allow approximately 50 % of
patients to return to their pre-injury sporting activity level. Hamstring grafts lead to
better preservation of extension, higher patient-reported outcome scores, and less
radiographic evidence of OA [17]. A recent study also reported a prevalence of
patellofemoral OA in 26 % of the patients 12 years after ACL reconstruction
function [18]. The prevalence of patellofemoral OA for the contralateral knee was
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6 %, but only 2.5 % for uninjured contralateral knee. Signiﬁcant associations were
also found between patellofemoral OA and increased age, tibiofemoral OA and
impaired function [18].
Table 17.2 Conventional treatments and associated limitations in the management of tendon and
ligament injuries
Type of
treatment
Aim of the
treatment
Approach Limitation Ref.
Conservative
management
– Control of pain
– Reduction of
inflammation
and swelling
– Rest
– Cryotherapy
– Injection therapy (corticosteroids,
sclerotherapy and hemoderivatives)
– Orthontics
– Continuous passive motion
– Restrictive bracing
– Ultrasounds
– Laser treatment
– Electrotherapy
– Exercises at strengthening and balance
– Initial phase of damage
– Limited success
– Fail to regenerate tissue
– Risk of disease/injury
progression
[13–
15]
Surgery
intervention
– Reduce the
symptoms
– Stabilize and
improve
articular
function
– Removal of damaged tissue (areas of failed
healing, ﬁbrosis and pathological nerve
ingrowth)
– Application of augmentation devices or
patches or recurring to auto and allo-grafts to
replace damaged tissue
– Long rehabilitation
– Instability
– Increased risk of failure
and recurrence
– Formation of scar tissue
and or adhesions
– Fail to regenerate tissue
– Loss of tissue
mechano-competence
associated to
functionality
– Mechanical mismatch
and tissue laxity
– Risk of nerve damage
and infection
– Expiration date
– No protection against
long term degenerative
changes
In autografts:
– Morbidity and functional
disability at the
harvesting site
– Poor tissue
integration/non-anatomic
placement
– Graft impingement or
tension
In allografts:
– Need for
immunosuppressive
drugs to avoid tissue
rejection
– Poor tissue
integration/non-anatomic
placement
– Risk of pathogen
transmission
– Graft impingement or
tension
[13–
16]
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Other approaches involving artiﬁcial augmentation devices are also available for
tissue reconstruction [19]. These include commercially available devices as LARS™,
Leeds-Keio, Kennedy ligament augmentation device, Dacron, Gore-Tex and Trevira
[20] being LARS one of the mostly used for ACL and PSCL. They offer advantages
over tissue grafts by avoiding donor tissue morbidity and providing improved knee
stability [19] and full weight bearing. Nevertheless they also have limitations and
several complications have been associated to the long term follow up with artiﬁcial
devices, namely, mechanical failure or mechanical mismatch with native tissues,
synovitis, chronic effusions, recurrent instability and early knee OA.
Although these systems have been used for decades now, their outcomes are still
controversial. Some studies with a 10 year follow up refer that the LARS™ system
should not be suggested as a potential graft for primary reconstruction of the ACL
[21] while others validate their application. Moreover, special indications have been
described in literature for the effective and safe use of some of these devices [21].
Despite the potential and interest generated using biological augmentation for
tendon and ligament reconstruction, surgeons do not seem convinced of their
bio-mimicry beneﬁts for the knee joint and preferentially choose artiﬁcial over
biological devices. Biological augmentation is often mediated by decellularized
mammalian-derived tissues, mainly from human (GraftJacket®), porcine
(Restore™), equine (OrthADAPT®) or bovine (TissueMend®) origin [22]. The risk
of immune-rejection and of zoonose transmission together with the lack of publi-
cations in recent years, limits the knowledge and clinical outcomes of patients
treated with these matrices.
Tendon morphology and functionality are intrinsically associated and function
depends on the highly organized hierarchy of parallel, crosslinked ﬁbrils of collagen
assembled from nano to macro structures. Partial or total loss of tendon and liga-
ment functionality is mainly caused by a poor alignment of collagen ﬁbrils in scar
tissue, resulting in signiﬁcant mechanical limitation of repaired tendons that never
match the properties of healthy non-injured tissue. Thus, the creation of artiﬁcial 3D
highly sophisticated and complex systems that recapitulate this hierarchical and
anisotropic architecture to support a complete regeneration of damaged tissues
while remaining mechanically competent is a challenge to overcome by tissue
engineering technologies.
17.4 Tissue Engineering Strategies for Tendon
and Ligament Regeneration
17.4.1 Tissue Engineering and Regeneration
Regeneration represents one of the most important biological processes, assisting
the renewal and remodeling of tissues and organs which have suffered physical
damage or injury. With regeneration the normal structure and function of the
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tissue/organ are completely restored into a functional level and homeostasis is
reestablished. On the other hand, this does not occur in tissue repair, a failed
attempt to regenerate, resulting in the synthesis of disorganized ﬁbrotic tissue with
inferior properties to the original healthy tissue [23]. Thus, tissue engineering and
regenerative medicine proposes alternative approaches combining living agents, the
cells, with 3D structures to mimic the biophysical and chemical cues of native
extracellular matrix, and/or bioactive molecules to biochemically stimulate cells
and the tissue milieu, to meet the demanding requirements of tissue regeneration.
17.4.2 Cell-Based Strategies for Tendon and Ligament
Tissues
The hypocellular and hypovascular nature of tendons and ligaments comparatively
to other tissues has been associated to a very limited natural healing capacity with
signiﬁcant drawbacks for a successful regeneration, especially when severe injuries
occur. Moreover, failure to regenerate increases the risk for progression of asso-
ciated diseases into nearby tissues, inflicting more pain and degeneration to the
already injured joint [5, 24]. Thus, it is not surprising that some potential regen-
erative approaches for tendon and ligament focus on cell based strategies to
overcome these limitations and accelerate a tissue regenerative response.
Tendon and ligament resident cells are an obvious choice [25] since these cells
are harvested from the target tissue and an eventual level of epigenetic memory
could match the desired cell response to meet regeneration in damaged tendons or
ligaments. In 2007 Bi and co-workers discovered a tendon stem/progenitor cell
population with functionally attractive features including universal stem cell
characteristics such as clonogenicity, multipotency and self-renewal capacity, and
with the capability to generate a tendon-like tissue after in vitro expansion and
in vivo transplantation [26]. Although isolating autologous cells from tendons and
ligaments is a feasible process, the harvesting of resident cells, even in limited
number, is not the most adequate option, as it may interfere with donor tissue
homeostasis, causing severe tissue morbidity. Cells harvested from a different donor
are a valid but not so desirable alternative, since tissue supply is limited and there is
an associated risk of rejection or disease transmission.
Pluripotent embryonic stem cells (ESCs) are an alternative source to tendon
cells, whose potential for the treatment of tendon injuries has been demonstrated in
a patellar defect of a rat model [27], resulting in improved mechanical and struc-
tural properties without teratoma formation. Nevertheless, the ethical issues asso-
ciated to the manipulation of human embryos, and the risk of tumor formation post
implantation limits advances in human ESC knowledge and prevents new insights
for regenerative medicine.
Induced pluripotent stem cells (iPSCs) technology also presents value for tendon
and ligament regeneration, as iPSCs can be reprogrammed into a wide range of cell
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types providing an inexhaustible source of autologous cells without the ethical
considerations of ESCs but still resembling and sharing some ESC characteristics.
A recent study reported that a treatment with iPSCs derived from neural crest stem
cells signiﬁcantly enhanced tendon healing in a window defect of a rat patellar
tendon with improvement in matrix synthesis and mechanical properties [28].
Despite interesting outcomes and a promising future for clinical applications, it is
necessary to improve the production efﬁciency of human iPSCs and assess human
safety application for cell therapy.
Adult tissues may also be interesting alternatives as stem cell sources. It is
widely described that practically all tissues in the human body have a stem cell
population that participates in the endogenous regeneration of the tissue. The role of
these stem cells is mediated by the release of trophic factors that influence tissue
milieu. Adult stem cells are not pluripotent as ESCs but can commit and differ-
entiate into several tissue lineages and have a high self-renewal capacity.
Bone marrow stem cells are the most studied stem cells of adult origin and were
shown to have tenogenic differentiation potential [29, 30]. Furthermore, human
bone marrow mesenchymal stem cells (MSCs) supported tendon healing when
implanted into artiﬁcially induced tendinitis in rat Achilles tendon, promoting
neovascularization and produced larger deposits of type I collagen and type III
collagen and better organization of the extracellular matrix [31]. No tumor for-
mation or excessive inflammatory reaction was locally detected at the rat tendon
[31].
Adipose tissue [32] and amniotic fluid [32] have been also reported to be
promising for tendon repair, having the ability to commit into a tenogenic phe-
notype as measured by increased genetic and protein expression of tendon related
markers, namely type I and III collagen, decorin, tenascin C and scleraxis under
supplemented culture medium. In comparison to other adult stem cell sources,
adipose tissue offers a more abundant source and less invasive procedures for
harvesting stem cells with immunomodulatory properties and long-term genetic
stability.
Adipose tissue-derived MSCs were applied to the treatment of induced tendinitis
of the superﬁcial digital flexor tendon in the horse [33]. The lesions that received
treatment with these cells presented a more organized and uniform tissue repair as
compared with the control limb, including less inflammatory inﬁltrate, greater
parallel arrangement of the ﬁbers, larger extracellular matrix deposits, and greater
type I collagen expression [33].
Despite the growing knowledge on regeneration mediated by stem cells and the
fact that bone marrow stem cells have already found a clinical niche in cell therapies
for the treatment of several (non-tendon/ligament) diseases, stem cell therapies for
tendon and ligament require further research in order to understand the mechanisms
of regeneration, recapitulate them in vitro and translate the appropriate stimuli in a
spatial-temporal manner toward successful cell-based therapeutic tools. The still
limited knowledge about the tenogenic process and associated markers together
with the lack of standardization of biochemical cocktails to induce in vitro teno-
genesis are holding back the understanding and recapitulation of tissue
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regeneration. However, it is expected that these drawbacks will be overcome in the
next few years and will bring signiﬁcant insights in therapeutics toward tendon and
ligament tissues.
17.4.3 Design and Fabrication of 3D Sophisticated
Scaffolds
As mentioned above, the complex hierarchical ECM is essential for tendon and
ligament functionality and responsible to be an instructive microenvironment for
resident tendon cells.
A key challenge in tendon and ligament TE is exactly the recreation of 3D
scaffolding biomaterials that can mimic this unique architecture and support tissue
regeneration while remaining mechanically competent [6, 7].
Being mechano-sensitive and mechano-responsive tissues, the cell response may be
assisted and guided by 3D structures that would recreate tendon microenvironment with
speciﬁc topographical and biophysical cues such as the substrate geometry and topography
of ﬁber based scaffolds. The incorporation of growth factors (GFs) and other bioactive
molecules within a 3D scaffold can also improve the biofunctionality of the system, once
GFs were shown to play a crucial part in tendon and ligament repair [34–41].
However, the development of tendon/ligament scaffolds is a nontrivial issue as
they should match the mechanical properties of the targeted tissue in order to allow
appropriate functionality, but progressively degrade over time at a rate matching
tissue regeneration while preserving the overall construct tensile properties and
reduce the risk of premature rupture. Thus, a suitable scaffold should be tailored
considering the properties of the biomaterials they are produced from, the scaffold
design and architecture as well as the processing technique [42].
Scaffold biomaterials can be synthetic, natural based or a combination of both.
Synthetic polymers are known for their higher processability being more versatile in
ﬁtting a wide range of properties and structural features, while natural polymers,
such as alginate, chitosan, hyaluronic acid are obtained from renewable and
abundant sources and may be biodegraded by enzymes naturally present in the
body. Moreover, the fact that the biological and chemical properties of the latter
share similarities to living tissues, in particular to the extracellular matrix, can be an
advantageous parameter for cellular recognition in TE strategies.
Several potential biomaterials for the development of tendon or ligament scaf-
folds and associated advantages are summarized in Table 17.3.
Aligned ﬁbrous materials have been among the preferred options as potential
scaffolds in tendons and ligaments [64–66] mainly due to the linear and ﬁbrillar
organization of collagen molecules into ﬁbrils, ﬁber bundles, fascicles and tendon
units. These materials can be obtained through different ﬁber fabrication tech-
nologies, but in the past few years electrospinning [64, 65] and electrochemical
alignment technique [46, 67] combined with textile techniques have been in the
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development forefront of hierarchical scaffolds for the proposed TE applications.
These strategies have been showing promising results in this ﬁeld and will be
discussed in more detail in the following sections.
17.4.3.1 Electrospinning
Electrospinning produces long continuous ﬁbers with controlled diameter from
nanometers to microns. The advantage of electrospinning comparing with other
conventional techniques is that the produced ﬁbrilar systems better mimic the
nanoscale morphological structure of tendon and ligament ECM, in order to provide
the topographical cues and promote cells contact guidance, increasing the potential
for regeneration.
Table 17.3 Examples of scaffold biomaterials that have been studied for tendon and ligament TE
strategies
Origin Biomaterial Processing
method
Advantages References
Natural Collagen Wet-spinning
Electrochemical
alignment
Reasonable
mechanical properties
Relatively slow rate of
degradation
Main component of
T/L
[43–46]
Silk Electrospinning
Knitting
Good mechanical
properties
Slow rate of
biodegradation
[39, 47–
51]
Alginate/CHT Wet-spinning Provide a proper
substrate for ﬁbroblast
growth with dense
type I collagen
production
[52]
Synthetic PLGA Electrospinning Easier to process
through different
techniques
Large scale production
with lower cost
Higher mechanical
properties comparing
with natural polymers
[39, 53]
PLLA Melt-spinning [54–57]
PGA [55]
PCL Freeze drying
Electrospinning
[58, 59]
Synthetic/naturals PLCL/Collagen Electrospinning Combination of the
best properties of
natural and synthetic
polymers
[60, 61]
PCL/CHT [62]
PCL/CHT/CNC [63]
T/L tendon/ligament, PLGA poly(lactic-co-glycolic acid), PLLA poly-L-lactic acid, PGA poly
(glycolic acid), PCL polycaprolactone, PLCL poly(L-lactide-co-e-caprolactone), CHT chitosan,
CNC cellulose nanocrystals
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Following this strategy it is possible to artiﬁcially reproduce the characteristic
anisotropic alignment of collagen ﬁber bundles in these tissues [68, 69].
This technique also enables the production of ﬁbers from different polymers
including those from natural origin, such as collagen, chitosan, hyaluronic acid and
silk ﬁbroin; or synthetic, for example poly(e-caprolactone) (PCL), poly(glycolide)
(PLGA), poly(L-lactide) (PLA). Using natural and synthetic polymeric blends it is
possible to combine in a single system the adequate mechanical properties from
synthetics and the favorable biological response of cells/tissue from natural based
biomaterials aiming to mimicking the natural ECM of tendon and ligament [53, 70,
71]. These include e.g., poly(L-lactide-co-e-caprolactone)/collagen [60, 61] or poly-
e-caprolactone/chitosan (PCL/CHT) [62, 72] aligned nanoﬁbrous scaffolds.
Several systems have been tested to produce aligned nanoﬁber mats, but high
speed rotating collectors forcing to an aligned nanoﬁber deposition is usually the
preferred strategy to produce T/L nanoﬁber scaffolds [65].
The resulting nano/microtopography of the scaffolds fabricated through this
technique has proven advantageous. Anisotropically aligned nanoﬁbrous scaffolds
provide tendon biomimetic cues that induced cell alignment through contact
guidance mechanisms, resulting in proved impact on cell alignment along the
nanoﬁber aligned axis, but also over stem cells differentiation, phenotype mainte-
nance as well as matrix deposition, while recreating the anisotropic mechanical
behavior of tendon tissues [24, 53, 62, 71, 73, 74]. Moreover, this type of
well-aligned ﬁber scaffolds has recently demonstrated to enable the multistep
tenogenic differentiation of hiPSCs in vitro and the resulting tissue engineered
constructs promoted tendon repair in vivo in a rat Achilles tendon model [66]. The
tenogenic commitment of these cells was assigned to the activation of the
mechanic-signal pathway resulting from the cytoskeletal rearrangement induced by
the scaffold’s topography [66].
Recreating the characteristic non-linear tri-phasic deformation behavior of ten-
dons and ligaments is also a very important feature to consider. The toe region
under low deformation (typically between 0–2 % strain), which results from the
uncramping of collagen ﬁbrils, is important in tendon/ligament biomechanics as
shock-absorbing feature to prevent tissue damage. Recent studies developed
crimped electrospun scaffolds [75–77]. The crimped pattern on electrospun ﬁber
mats provide a closer mimic of the nonlinear biomechanical behavior of collagen
ﬁbrils, which facilitate nonlinear stiffening of the tissue under increasing tensile
strains [75]. Furthermore, tendon cells cultured on crimped nanoﬁbers showed a
higher level of tolerance toward externally applied strain than those cultured on the
straight nanoﬁbers, suggesting that the crimping feature in nanoﬁber-based scaf-
folds has a high potential for tendon and soft connective tissue repair.
Considering the anatomic load-bearing function of tendon and ligaments, the
tensile behavior of the proposed scaffolds are also critical parameters. Scaffold’s
design for tendon/ligament applications should match the mechanical properties of
native tissues, not only to minimize stress-shielding effects that may lead to dis-
organized tissue growth, but also to provide a temporary replacement for immediate
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function with reduced probability of premature rupture after repair, while allowing
tissue regeneration over time [78].
The tensile properties reported for native tendons and ligaments are in the range
of 5–100 MPa of ultimate tensile strength and 20–1200 MPa of Young’s modulus,
while strain at failure varies much less and typically fall in the range of 10–15 %
[79]. A recurrent concern about the relevance of electrospun scaffolds in
tendon/ligament TE strategies is related with their reported limited mechanical
performance. Electrospun scaffolds have been preferentially fabricated based on
semi-crystalline biodegradable polyesters and their tensile mechanical properties
generally range from 1 to 25 MPa in ultimate tensile strength and 1–350 MPa in
elastic modulus [14]. While it may be sufﬁcient when applied in comparatively low
tensile demanding tendon/ligament tissues such as those from human shoulder, they
are not satisfactory when targeting high tensile demanding tissues such as patellar,
Achilles tendons or ACL. Our research group has recently addressed this issue by
reinforcing tendon/ligament ﬁbrous scaffolds made of a natural/synthetic polymer
blend of PCL/CHT with the incorporation of cellulose nanocrystals (CNC) which
are bioderived nanoﬁllers [63]. The incorporation of low CNC contents (up to 3 wt
%) into PCL/CHT polymer blend to form nanoﬁber bundles had a signiﬁcant
toughening effect (increased 132 % the Young’s modulus and 83 % ultimate tensile
strength without signiﬁcantly affecting strain at failure). Moreover, this reinforce-
ment was achieved while maintaining the structural cues for the superior biological
performance (Fig. 17.3). This may thus be a suitable strategy to explore in order to
fabricate tendon/ligament mimetic nanoﬁbrous structures balanced with appropriate
mechanical performance and expand their potential of applications in this ﬁeld.
Nonetheless, electrospinning typically produces 2D ﬁber mats, restricting their
further processing into higher hierarchical 3D structures. Thus, scaffolds are limited
in terms of dimensions, handling and load-bearing capacity. Different strategies
have been devised in recent years [80], including rolling [81] or twisting [82]
pre-cut sections from aligned nanoﬁber to produce nanoﬁber bundles, or their
assembly into higher 3D hierarchical structures through standard textile such as e.g.
weaving or braiding [24, 74]. These strategies allow producing aligned nanoﬁber
scaffolds of relevant dimensions, while enabling to tune their general mechanical
properties (stiffness, strength, strain and maximum load) to mimic the typical
tri-phasic biomechanical behavior of tendons and ligaments by artiﬁcially recreat-
ing the characteristic toe region in a load-displacement curve.
However, these fabrication strategies are less practical in terms of clinical
translation, as well as on their scale up production and standardization because they
are based on the typical rotating collection drums or wheels which produce a 2D
nanoﬁber sheet or bundle of limited dimensions. Therefore, the production of
continuous electrospun nanoﬁber yarns as mimicry of tendon fascicles is suitable
for further assembling into higher hierarchical 3D structures through standard
textile techniques and devices would be a signiﬁcant breakthrough in T/L TE.
Several strategies for their production have been developed in the past few years
[65] and recently Mouthuy et al. devised an automated method that enables the
manufacture of continuous electrospun ﬁlaments with the potential to be integrated
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into existing textile production lines [65, 83]. In practice the proposed technology is
a multistep process (Fig. 17.4) relying on the use of a wire guide to collect a
nanoﬁber mesh which is then detached as a long and continuous thread, the thread
is drawn to align the nanoﬁbers and then is twisted to create multiﬁlament yarns.
This concept, the ﬁrst of his kind, is still in the early stages of development and
lack optimization. However, further developments are expected in coming years on
biotextile scaffolds based in continuous nanoﬁber yarns for T/L TE.
In a different strategy to produce 3D hierarchical scaffolds for T/L TE, Yang
et al. recently proposed a multilayered ﬁber-hydrogel composite approach [84]. The
concept consisted in simultaneously co-electrospin PCL and methacrylated gelatin
using the typical rotating collection drum. The 2D ﬁber mat sheets are wet with
photoinitiator solution and then photocrosslinked to produce the ﬁber-hydrogel
composite scaffolds. Stacking multiple sheets prior to photocrosslinking allows the
production of multilayered scaffolds as well as the encapsulation of cells, if desired,
within layers. Although the results support that a combination of nanoﬁbrous
Fig. 17.3 Optical (a) and high magniﬁcation SEM (b) micrographs of aligned nanoﬁber bundles
of PCL/CHT/CNC3. c SEM micrographs of hTDCs seeded on PCL/CHT/CNC3 nanoﬁbrous
scaffolds with aligned topography after 10 days of culture. Confocal microscopy micrographs of
the hTDCs seeded on PCL/CHT/CNC3 nanoﬁbrous scaffolds with random (d) and aligned
(e) topography (blue nuclei stained with DAPI; red actin ﬁlaments stained with
rhodamine-conjugated phalloidin). f Respective 2D FFT frequency plots (insets) and normalized
radial intensity plotted against the angle of rotation for hTDCs cultured on random and aligned
nanoﬁbers. Scale bar 300 µm (a), 1 µm (b), 10 µm (c). Reprinted from Ref. [63]. Copyright 2016
WILEY VCH Verlag GmbH & Co. KGaA, Weinheim. With permission from John Wiley and
Sons
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structures and photocrosslinked hydrogels may closer mimic the T/L structure,
providing the aligned topographical cues and contributing for the tenogenic dif-
ferentiation of hASCs [84], the ﬁnal mechanical properties are far from ideal (ul-
timate tensile strength of 1.45 ± 0.19 MPa), which restricts their potential
application in this ﬁeld.
17.4.3.2 Electrochemical Alignment Technique
The so called electrochemical alignment technique is an interesting strategy that
allows producing anisotropically aligned collagen bundles through a process based
on the pH gradient created between two parallel electrodes [46, 67, 85]. This
strategy was ﬁrstly proposed for TE of connective tissues by Akkus group [86], that
have been developing this technique, culminating in a recent proposed system for
Fig. 17.4 Method used for the fabrication of continuous electrospun ﬁlaments and multi ﬁlament
nanoﬁber yarns. a Sketch of the manufacturing process. The method consisted in spinning the
polydioxanone (PDO) ﬁbres on a stainless steel wire progressing at a speed of 0.6 mm s−1
underneath the electrospinning nozzle (B1 wire supply, B1′ wire collection, B2 electrospun
ﬁlament collection, S cutter wheel,W wiper). The electrospun material was then separated from the
wire in the form of a continuous ﬁlament. (1–4) Scanning electron microscope images taken at
different positions in the process. Fibers are mostly collected on the side of the wire exposed to the
electrospinning jet (1) compared to the hidden side, (2) the mesh can be separated from the wire,
(3) as one continuous thread of randomly oriented submicroﬁbres (4). b The stretched ﬁlaments (1)
were assembled into 4-plied yarns by manually twisting four ﬁlaments together in a right-hand
direction (‘S’ turn) at 400 twists/m. (2) Four of these were then twisted together in a left-hand
direction (‘Z’ turn) at 200 twists/m to fabricate a cord yarn (3, 4). Adapted from Ref. [83] with
permission
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the production of continuous electrochemically aligned collagen (ELAC) threads
[67].
Their pioneer study has shown that the ELAC threads exhibit a collagen ﬁbrillar
organization that mimics the packing density, alignment and strength of T/L tissues
[86]. Following studies evaluated the effect of several processing parameters in the
mechanical and structural properties of ELAC threads, such as buffer concentration
and incubation time [87], crosslinking degree (with genipin) [88] and addition of
proteoglycan (decorin) to the collagen matrix [89]. Ultimately, the optimization
resulted in the improvement of the of ELACs wet ultimate tensile strength to the
range of 80–110 MPa, elastic modulus of 600–900 MPa and strain of 10–15 %,
which approximates the values for several native tendons.
Gurkan et al. compared the ability of tendon-derived ﬁbroblasts (TDFs) and
bone marrow stromal cells (MSCs) to migrate and populate single and braided
ELAC threads crosslinked with genipin [46]. The results support the
non-cytotoxicity of crosslinked ELACs and that in vitro both cell types colonize
and migrate over ELAC threads more successfully than in singles threads [46]. It
was also demonstrated that different crosslinking degrees and threads coagulation
treatments have an impact over hMSCs adhesion and proliferation, probably
resulting from the different threads stiffness [88]. Moreover, the anisotropically
aligned topography of the genipin crosslinked ELAC threads proved to promote
tenogenic differentiation of hMSCs [90] and ELAC braided scaffolds showed
in vivo biocompatibility and biodegradability after 8 months in a rabbit patellar
tendon model [91].
Recently Younesi et al. developed a custom made rotating electrode electro-
chemical alignment device able to produce ELAC threads in a continuous mode
[67]. Applying biotextile techniques, woven 3D-biotextile scaffold were fabricated
with these threads (Fig. 17.5A). The 3D woven structure not only mimics the
hierarchical structure and non-linear tensile behavior of native tendons, as MSCs
seeded on the scaffold also express increased tendon speciﬁc markers when com-
pared to randomly oriented collagen gels. This 3D-biotextile scaffold woven purely
from collagen has a remarkable high porosity (80 %) which promotes cell seeding
across the bioscaffold (Fig. 17.5B), while the anisotropically aligned substrate
texture topographically stimulates tenogenesis [67].
These woven 3D-biotextile scaffolds were tested to span a gap defect between
the infraspinatus muscle and humerus in rabbit [92]. Although the main objective
of the study was to develop the suturing scheme for grafting the scaffold, it was
shown that the graft repair was able to withstand similar load as the direct tendon
reattachment, thus demonstrating the potential of this system as a full load-bearing
construct for segmental defects.
Overall, the previously described outcomes from the in vitro and in vivo studies
on ELAC threads scaffolds are encouraging and promising for T/L TE applications.
However, it is also important to refer that, considering the basic principles of this
fabrication technology, there might be a particular limitation in terms of polymer
matrix option. In fact, with the exception of one study [89], scaffolds have been
exclusively based on type I collagen. Also, the performance of ELAC based
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scaffolds in T/L TE is still limited and has not yet been compared with other
materials produced e.g. by electrospinning, as discussed on previous section, or
decellularized tendon-derived matrix [93], which share the same basic composition
of ELAC scaffolds. This lack of versatility may reveal critical in case of failure at
any developmental stage because it restricts the approaches that can be followed to
solve possible drawbacks.
17.5 Conclusions
In this chapter, it was presented the important role of tendon and ligament tissues in
articular biomechanics and their unique hierarchical organization. Injuries associ-
ated to these tissues are a common problem and a leading cause of joint disability
affecting the population in general, consequently influencing their quality of life.
The current conventional techniques to manage this problematic, in particular in
knee ligaments and tendons, were presented and discussed. In spite of the reduction
of the symptoms, i.e. the pain control and the reduction of the inflammation and
swelling, the mid and long term outcomes may progress to knee OA and/or T/L
weakening. Moreover, due to the limitations of nonsurgical approaches, the
resource to surgery remains the most recurrent option to reduce the symptoms and
provide some short to mid term quality of life to patients.
In this sense, TE may become the most promising alternative therapy to achieve
a complete regeneration of the damaged tissue, recovering its native biomechanical
functionality. Nevertheless, despite the remarkable progresses made in the last few
years, there are still signiﬁcant challenges to overcome in this ﬁeld. It spans from
the establishment of cell sourcing and differentiation protocols, to the reﬁnement of
3D scaffold designs that can simultaneously mimic the hierarchical and anisotropic
architecture of T/L and match their biomechanical behavior.
The continuous developments and promising outcomes are expected to bring
T/L TE strategies a step closer to clinic practice in a near future.
b Fig. 17.5 A Schematic of the rotating electrode electrochemical alignment device (a). The main
parts of the device are: power supply for providing voltage for the electrochemical cell, the syringe
pump, rotating electrodes wheel and collection spool. Compensated polarized image in the top left
inset demonstrates the collagen molecules to be aligned parallel to the longer axis of the thread as
manifested by the blue color. Closely packed and aligned topography of the ﬁber surface is evident
from the electron microscopy image. b Collagen ﬁber made by a rotating electrode electrochemical
aligning device (REEAD), c yarn made by twisting three collagen threads, d pin-setup for weaving
the collagen scaffold, e the resulting woven collagen scaffold, f and two scaffolds to demonstrate
the consistency of fabrication. B A macrograph of cell‐seeded scaffold where the cellular F‐actin
cytoskeleton is labeled. Cells have profusely covered the entire scaffold with elongated
morphology. Reprinted from Ref. [67]. Copyright 2014 WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim. With permission from John Wiley and Sons
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